The daily business briefing: November 9, 2020

Published Nov 09 2020 at 12:55 PM GMT
  • A coronavirus vaccine candidate in development from Pfizer and BioNTech was found to be more than 90 percent effective against COVID-19 in a first interim analysis, the companies announced on Monday.
  • In an analysis of 94 subjects infected with the coronavirus, the companies said that the early data "indicates a vaccine efficacy rate above 90 percent.
  • This was a better rate than anticipated.
  • Pfizer previously said it could seek emergency use authorization from the Food and Drug Administration for its vac.



  • Published Nov 9, 2020 12:55 PM GMT